AZD2389
AZD2389 is a potent and orally active FAP inhibitor. AZD2389 can be used for the study of metabolic dysfunction-associated steatohepatitis[1].
Product Specifications
CAS Number
2791472-12-1
UNSPSC
12352005
Target
FAP
Related Pathways
Immunology/Inflammation
Field of Research
Metabolic Disease
Purity
99.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1[C@@H](CSC1)C#N)CNC(C2=CC=NC3=C2C=C(N4CCOCC4)C=C3)=O
Molecular Formula
C20H21N5O3S
Molecular Weight
411.48
References & Citations
[1]AZD2389, a first in class candidate drug for the treatment of metabolic dysfunction-associated steatohepatitis.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
